Nvidia AI chips targeted in China customs crackdown- FT
Palomar Holdings (NASDAQ:PLMR) CEO and Chairman Mac Armstrong sold a total of $580,090 in company stock on September 22, 2025. The sales involved 5,000 shares of common stock, with prices ranging from $115.5431 to $116.4228. The insurance company, currently valued at $3.14 billion, has shown robust financial performance with revenue growth of 53% over the last twelve months. According to InvestingPro analysis, the stock appears to be trading below its Fair Value.
The transactions were executed in two separate sales. The first sale involved 2,300 shares at a weighted average price of $115.5431, with individual prices ranging from $115.00 to $115.98. The second sale consisted of 2,700 shares at a weighted average price of $116.4228, with prices ranging from $116.07 to $116.80. Despite a 14% decline in share price over the past six months, the company maintains a GREAT financial health score according to InvestingPro metrics.
Following the transactions, Armstrong directly owns 73,342 shares of Palomar Holdings, Inc., which includes 2,652 shares purchased pursuant to the Palomar Holdings, Inc. 2019 Employee Stock Purchase Plan (ESPP). Armstrong also indirectly owns 372,388 shares through the Armstrong Family Trust. For deeper insights into Palomar’s valuation and growth prospects, including 7 additional key ProTips and comprehensive financial analysis, visit InvestingPro.
In other recent news, Palomar Holdings reported strong financial results for the second quarter of 2025, with earnings per share of $1.76, surpassing analyst expectations of $1.67. The company’s revenues reached $496.3 million, exceeding projections by 8.1%. Despite these positive figures, various analysts have adjusted their price targets for the company. JPMorgan lowered its price target to $158, citing slower growth in the earthquake insurance segment, while maintaining an Overweight rating. Keefe, Bruyette & Woods also reduced their target to $172, attributing the change to "unusual seasonality" but still recognizing strong results with an Outperform rating. Piper Sandler adjusted their target to $151 due to concerns over a higher-than-expected expense ratio, despite Palomar exceeding earnings estimates. These adjustments reflect a range of perspectives on Palomar’s recent performance and future outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.